Literature DB >> 35535070

First Report of a Paediatric Collision Tumour in the Liver Recognised After Liver Transplantation: Blissful Ignorance Has Benefits!

Sathish K Krishnan1, Karattupalayam S Mouleeswaran2, Prasanna Gopal1, Rajanikanth Patcha1, Somashekara H Ramakrishna3, Perumal Karnan3, Selvakumar Malleeswaran4, Joy Varghese5, Mettu S Reddy1.   

Abstract

Liver tumours are uncommon in the paediatric population, constituting 1-2 % of all paediatric tumours and 4% of all paediatric liver tumours. Hepatoblastoma followed by hepatocellular carcinoma is the most common tumours in this age group. Simultaneous development of two discrete liver tumours of distinct histologies (collision tumour) has been occasionally reported in adults but never in children. We hereby present the first reported case of hepatic collision tumours (hepatocellular carcinoma and cholangiocarcinoma) in the explant liver of a child who underwent living donor liver transplantation for end-stage liver disease and severe hepatopulmonary syndrome. The manuscript describes the clinical, radiological and histopathological findings of this case and also highlights the dilemma associated with management of this case had the diagnosis been made in the preoperative setting and also about the proposed management plan for this case in the postoperative period.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AFP, alpha fetoprotein; CA 19-9, carbohydrate antigen; CC, cholangiocarcinoma; CECT, contrast-enhanced computed tomography; CPAP, continuous positive airway pressure; Ck, cytokeratin; HCC, hepatocellular carcinoma; HPS, hepatopulmonary syndrome; LDLT, living donor liver transplantation; LT, liver transplant; MAA scan, macro albumin aggregate scan; PELD, pediataric end-stage liver disease score; POD, postoperative day; UCSF, University of California San Francisco; UGI, upper gastrointestinal; cholangiocarcinoma; collision tumour; hepatocellular carcinoma; liver transplant; paediatric liver transplant

Year:  2021        PMID: 35535070      PMCID: PMC9077198          DOI: 10.1016/j.jceh.2021.05.006

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  12 in total

1.  Synchronous liver cancers: A rare tumor combination in an elderly Japanese woman.

Authors:  Dorothy M Shigaki; Ashlee C Nekoba; Jasmine Y H E Ide; John M Hardman; Jinichi Tokeshi
Journal:  Hawaii Med J       Date:  2006-06

2.  Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.

Authors:  Z D Goodman; K G Ishak; J M Langloss; I A Sesterhenn; L Rabin
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

Review 3.  Collision and composite tumors; radiologic and pathologic correlation.

Authors:  Calvin T Sung; Anup Shetty; Christine O Menias; Roozbeh Houshyar; Shreya Chatterjee; Thomas K Lee; Paul Tung; Mohammed Helmy; Chandana Lall
Journal:  Abdom Radiol (NY)       Date:  2017-12

4.  Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment.

Authors:  G Sapisochin; M Facciuto; L Rubbia-Brandt; J Marti; N Mehta; F Y Yao; E Vibert; D Cherqui; D R Grant; R Hernandez-Alejandro; C H Dale; A Cucchetti; A Pinna; S Hwang; S G Lee; V G Agopian; R W Busuttil; S Rizvi; J K Heimbach; M Montenovo; J Reyes; M Cesaretti; O Soubrane; T Reichman; J Seal; P T W Kim; G Klintmalm; C Sposito; V Mazzaferro; P Dutkowski; P A Clavien; C Toso; P Majno; N Kneteman; C Saunders; J Bruix
Journal:  Hepatology       Date:  2016-08-24       Impact factor: 17.425

5.  Synchronous development of HCC and CCC in the same subsegment of the liver in a patient with type C liver cirrhosis.

Authors:  Takuya Watanabe; Jun Sakata; Takashi Ishikawa; Yoshio Shirai; Takeyasu Suda; Haruka Hirono; Katsuhiko Hasegawa; Kenji Soga; Koichi Shibasaki; Yukifumi Saito; Hajime Umezu
Journal:  World J Hepatol       Date:  2009-10-31

6.  Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.

Authors:  Youngmee Kwon; Seung Kyu Lee; Jung-Sun Kim; Jae Y Ro; Eunsil Yu
Journal:  Mod Pathol       Date:  2002-10       Impact factor: 7.842

7.  Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.

Authors:  William R Jarnagin; Sharon Weber; Satish K Tickoo; Jonathan B Koea; Sam Obiekwe; Yuman Fong; Ronald P DeMatteo; Leslie H Blumgart; David Klimstra
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

Review 8.  Tumors of the liver in children.

Authors:  Rebecka L Meyers
Journal:  Surg Oncol       Date:  2007-08-21       Impact factor: 3.279

9.  An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma.

Authors:  J Haratake; H Hashimoto
Journal:  Liver       Date:  1995-02

10.  Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports.

Authors:  Kyu Sik Jung; Kyeong Hyeon Chun; Gi Hong Choi; Hyae Min Jeon; Hye Sun Shin; Young Nyun Park; Jun Yong Park
Journal:  BMC Res Notes       Date:  2013-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.